AC
MRNA icon

Aristides Capital’s Moderna MRNA Stock Holding History

Aristides Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,000
Closed -$552K – 278
2025
Q2 		$552K Hold
20,000
– – 0.11% 99
2025
Q1 		$567K Buy
+20,000
New +$710K 0.17% 91
2022
Q2 		– Sell
-1,268
Closed -$218K – 188
2022
Q1 		$218K Buy
+1,268
New +$213K 0.13% 136

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Aristides Capital's MRNA Position: Q3 2025 in Review

Aristides Capital sold out of Moderna (MRNA) in Q3 2025, closing a stake of 20,000 shares — an estimated $552K sold.

Aristides Capital first reported a position in MRNA in Q1 2022 and held it in 3 quarters. The position peaked at $567K in Q1 2025. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Aristides Capital reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Aristides Capital sold 20,000 Moderna shares in Q3 2025, an estimated $552K.
  • Aristides Capital first reported a position in Moderna in Q1 2022 and held it in 3 quarters.
  • Aristides Capital's Moderna position peaked at $567K in Q1 2025.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Aristides Capital's 13F filing for Q3 2025, filed 13 Nov 2025.